Torrent Pharma collaborates with Boehringer Ingelheim India to co-market its anti-diabetic drug, its fixed dose combinations in India Ruchika Sharma14 Dec 2022 4:50 PM ISTAhmedabad: Torrent Pharmaceuticals Ltd has entered into a strategic alliance with Boehringer Ingelheim India Private Limited to co-market Cospiaq...
Empagliflozin improves outcomes in HF with preserved EF irrespective of BP: the EMPEROR-Preserved trial Medha Baranwal13 Dec 2022 10:30 AM ISTGermany: Empagliflozin reduces the risk of heart failure (HF) hospitalization or cardiovascular (CV) death in HRpEF (heart failure and preserved...
Empagliflozin as add-on therapy improves quality of life in diabetes patients Medha Baranwal28 Nov 2022 10:15 AM ISTPunjab: Empagliflozin can be recommended as an add-on medication in type 2 diabetes (T2D) patients with hypertension with regards to improving their...
Empagliflozin reduces risk of disease progression and death in high-risk CKD patients: NEJM Medha Baranwal7 Nov 2022 10:30 AM ISTUK: Empagliflozin therapy in patients with chronic kidney disease (CKD) lowers the risk of disease progression or death from cardiovascular causes in...
Dual or single SGLT inhibition: which is more beneficial for type 2 diabetes? Study sheds light Medha Baranwal19 Oct 2022 9:30 AM ISTIn type 2 diabetes patients, the study did not indicate different clinical impacts of dual and single SGLT inhibition.Germany: Inhibition of...
Empagliflozin proves beneficial in acute myocardial infarction: EMMY trial Dr. Kamal Kant Kohli11 Sept 2022 7:30 PM ISTAUSTRIA: Acute myocardial infarction (MI) patients who receive the SGLT2 inhibitor empagliflozin (Jardiance) early after the MI have improved markers...
Increasing empagliflozin dose provides significant clinical benefits in type 2 diabetes: Study Medha Baranwal18 Aug 2022 7:30 PM ISTJapan: Switching from low-dose to high-dose SGLT2 inhibitor empagliflozin provides significant clinical benefits in patients with type 2 diabetes...
Increased dose of Empagliflozin may improve Glycemic control in T2 Diabetes patients Dr.Niharika Harsha B21 July 2022 7:30 PM ISTResearchers have found in a recent study that increasing the dose of Empagliflozin in Patients with Type 2 Diabetes significantly improved certain...
Add on Empagliflozin to automated insulin delivery improves glycemic control in type 1 diabetes Dr. Hiral patel19 July 2022 11:00 AM ISTUSA: A new study showed that the use of empagliflozin as an adjunct to automated insulin delivery (AID) improved glycemic management in adults with...
Zydus Lifesciences bags USFDA approval for Empagliflozin, Metformin Hydrochloride Tablets Ruchika Sharma11 July 2022 12:23 PM ISTThe drug will be manufactured at the group’s formulation facility at SEZ, Ahmedabad, India.
Empagliflozin may reduce serum uric acid in HF patients, lower mortality risk: EMPEROR-reduced trial Medha Baranwal10 July 2022 8:45 PM ISTGermany: In patients with heart failure, hyperuricemia is a common comorbidity and is an independent predictor of advanced disease severity and...
Early empagliflozin initiation induces diuresis in decompensated HF without worsening kidney function Medha Baranwal2 July 2022 12:45 PM ISTGermany: A recent study in Circulation revealed that in patients with acute decompensated heart failure, early empagliflozin addition to standard...
